/PRNewswire/ - Zucara Therapeutics Inc., a diabetes life sciences company developing the first therapeutic to prevent insulin-induced hypoglycemia (low blood.
/PRNewswire/ North America s clinical research leader, Centricity Research, announced that Aventiv Research has merged with the organization, extending the.